Spectrum News| April 2025
Spectrum MDs Jeff Haywood and Steve LeSieur Named Top Healthcare Investors of 2025
BOSTON, MA and SAN FRANCISCO, CA, April 30th, 2025 - Spectrum Equity’s Jeff Haywood and Steve LeSieur have been named for the fourth time to GrowthCap’s overall top health investors for 2025.
“This year’s awardees were selected for their deep sector expertise, leadership, and ability to navigate the ever-evolving healthcare landscape,” GrowthCap said in a statement. “Their areas of focus include healthcare software, medical technologies, biotechnology, healthcare services, the connected patient experience, and other related areas. In addition to their investment acumen, these investors have demonstrated an ability to provide unique strategic and/or operational insights that drive value for their portfolio companies.”
Jeff and Steve co-lead Spectrum’s healthcare investments, including companies like GoodRx (NASDAQ: GDRX), Payer Compass (acquired by Zelis Healthcare), Datassential (acquired by New Mountain Capital), and MedHOK (acquired by Hearst Health).
“It’s a privilege to partner with companies that sustainably benefit the healthcare system,” said Jeff. "The entrepreneurs we support are building lasting solutions that make care more accessible, more affordable, and more effective — and we’re honored to be part of that journey.”
“We’re proud to support healthcare companies that are improving outcomes and increasing access,” added Steve. "It’s inspiring to work alongside leaders who are driving meaningful change in the lives of patients, providers, and communities.”
Read their full bios and see the complete list of GrowthCap 2025 Top Healthcare Investors here.
Spectrum Equity submitted the nomination to be considered for the GrowthCap Top Healthcare Investor list and has paid a fee to promote/distribute this award after designation was announced 04/2025.
Content contained in this blog post is not intended to and does not constitute investment advice. Your use of the information in this blog post and materials linked is at your own risk. Spectrum Equity does not make any guarantee or other promise as to any results that may be obtained from using this content. No one should make any investment decision without first consulting his or her own financial advisor and conducting his or her own research and due diligence. Past performance is not indicative of future results, and there is a possibility of loss in connection with an investment in any Spectrum Fund. To the maximum extent permitted by law, Spectrum Equity disclaims any and all liability in the event any information, commentary, analysis, and/or opinions prove to be inaccurate, incomplete or unreliable, or result in any investment or other losses. The specific companies identified above does not represent all of Spectrum’s investments, and no assumptions should be made that any investments identified were or will be profitable.